Page 46 - Clinical Development News Today

Cormica Bradford, a division of Cormica says it is proud to announce a significant expansion of its laboratory capabilities.

Access to opioids such as fentanyl can lead to abuse but now two companies have signed an agreement to reduce the abuse potential while making sure they are still accessible to those who need them.

Op zoek naar een nieuwe IT baan? Bekijk de vacature R&D Engineer in Nijmegen. Bekijk welke bedrijven vacatures open hebben staan en solliciteer direct!

WNS supports the research and brand teams of more than 30 life sciences companies. The company believes its comprehensive pharma market research capabilities help clients in assimilating information from various data sources.

Commercial-stage biopharma company, Hutchmed, has good news for adults with primary immune thrombocytopenia (ITP).

Earlier this week, biopharma company Mind Medicine (MindMed) (NASDAQ: MNMD) released latest clinical trial results on repeated sub-perceptual doses of its LSD compound, MM-120, in adults with ADHD. The company also provided a corporate update and outlook for 2024.

ConcertAI Highlights 2024 Partnerships, Strategy, Business Results, and AI Roadmap at 42nd Annual J.P. Morgan Healthcare Conference

Introduced CARA™, the predictive and generative AI Platform powered by multi-modal Real-World Data, enabling precision oncology, accelerating clinical trials, increasing patient access, driving improved patient

Informatics software developer supporting R&D, ACD/Labs, has formed a collaboration with MilliporeSigma, the US and Canada Life Science business of Merck KGaA.

Evotec’s end-to-end integrated research and development platform will be able to advance drug discovery for two drug targets which is why it has joined forces with the Crohn’s & Colitis Foundation.